 x 0
 x 0
|
I prefer they get new project to boost their prices profit..😁
lifeisgood ( Date: 15-Mar-2021 09:38) Posted:
| if IPO Oiltek, Koh Eco should distribute " in-specie" oiltek shares to shareholders so that they can trade oiltek freely. |
|
|
|
Good Post
Bad Post
|
x 0
x 0
|
I guess should be positive news... Get ready to Cheong after lift halt. 🎉 🎉 🎉
ahberngh ( Date: 15-Mar-2021 08:45) Posted:
Hope it is a new contract.
But I suspect may have something to do with listing of Oiltek. |
|
|
|
Good Post
Bad Post
|
x 0
x 0
|
when this counter be strong as CDL 😁
|
|
Good Post
Bad Post
|
x 0
x 0
|
Look like there subsidiary companies.... Power..🤔
wiltay ( Date: 11-Mar-2021 15:13) Posted:
going into biotechnology, life and medical science.. nice
wiltay ( Date: 11-Mar-2021 15:10) Posted:
|
|
|
|
|
Good Post
Bad Post
|
x 0
x 0
|
Today no power.. 🤔
wiltay ( Date: 11-Mar-2021 08:23) Posted:
yes.... Good sign.. undervalue stock will be aware soon.. hahahaha
spursfan ( Date: 10-Mar-2021 17:12) Posted:
| yes good momentum from last week. added 4 pips already. vol, also picking up and up on bad day for penny stocks. good sign |
|
|
|
|
|
Good Post
Bad Post
|
x 0
x 0
|
How much this counter worth? 30ct,40cts etc...?
|
|
Good Post
Bad Post
|
x 0
x 0
|
Up 0.002cts 👍
|
|
Good Post
Bad Post
|
x 0
x 0
|
Sound good 👍 .
wiltay ( Date: 10-Mar-2021 10:20) Posted:
Hopefully koh eco is involve government' s plan of fight against climate change.
spursfan ( Date: 10-Mar-2021 09:52) Posted:
| Yes it is a plus for the coy that they are into environmental friendly industry which will be the trend in the future. |
|
|
|
|
|
Good Post
Bad Post
|
x 0
x 0
|
By the way.. anyone can explain what is bio_refinery and bio_energy..?
wiltay ( Date: 28-Feb-2021 18:01) Posted:
wiltay ( Date: 28-Feb-2021 17:59) Posted:
Be patient a bit lah...
This counter not just into construction sector but also into Bio-refinery and bio-energy which look very
optimistic. I am looking forward for good dividend next round.
|
|
|
|
|
|
Good Post
Bad Post
|
x 0
x 0
|
🤔 😱 WWII.... U survived throughout.... Sure bo?
Sibehboeng ( Date: 08-Mar-2021 22:06) Posted:
Sleep very long liao. Have been holding this counter since it was in the 40s.
Laihuat68 ( Date: 08-Mar-2021 20:26) Posted:
| I saw the sgx info for this coy, seem to be profitable from 2016 until pre covid19
And now look like it picking up. I think is a sleeping dragon. Lol.... |
|
|
|
|
|
Good Post
Bad Post
|
x 0
x 0
|
I saw the sgx info for this coy, seem to be profitable from 2016 until pre covid19
And now look like it picking up. I think is a sleeping dragon. Lol....
|
|
Good Post
Bad Post
|
x 0
x 0
|
Now up 0.002..Not bad.. this week can up 4cts Bo? 🤔
|
|
Good Post
Bad Post
|
x 0
x 0
|
Finally got some aware of this potential counter..
|
|
Good Post
Bad Post
|
x 0
x 0
|
When is the coming financial result out???
|
|
Good Post
Bad Post
|
x 0
x 0
|
1.12 clear.. 👍
halleluyah ( Date: 03-Mar-2021 09:37) Posted:
|
|
|
Good Post
Bad Post
|
x 0
x 0
|
Better prospects expected for Raffles Medical Group in FY2021: analysts
amala Balakrishner Published on Tue, Mar 2, 2021 / 11:38 PM GMT+8 / Updated 1 hour ago
Analysts are upbeat on the prospects of healthcare services provider Raffles Medical Group for they expect FY2021 ending in December to bring it ?some normalisation?.
In its recent results for FY2020, the group reported earnings of $65.9 million, up 9.3% y-o-y thanks to its provision of new services such as the Covid-19 Polymerase Chain Reaction (PCR) and serology testing.
In this time, its revenue was up 8.8% on year to $568.2 million, following an 18.4% growth in the performance of its healthcare services segment, possibly due to Covid-19 related works.
This was a ?positive surprise? to CGS-CIMB analyst Cezzanne See who had expected Raffles Medical?s income to come in it around $500 million in FY2020.
Maybank Kim Eng analyst Lai Gene Lih was similarly surprised, particularly by the group?s 2H2020 PATMI (profit after taxes minus interests) which had risen 50% on year to hit $46.8 million.
?This was ahead of our and street?s expectations,? she says in a research note. Lai attributes this to: activities related to the Covid-19 battle and the government?s wage support.
Looking ahead, the group?s ?management expects normalisation of most of Raffles Medical Group?s operations within FY2021, including the return of some foreign patients,? Lai notes in a research note.
She is expecting these foreign patients to return, especially to the group?s hospitals in China, since the Covid-19 vaccination has been taking place globally.
PhillipCapital analyst Tay Wee Kuang reckons this will be supported by the completion of the upgrading works at RaffleshospitalBeijing such that it can now support inpatient services and offer minimally-invasive surgeries.
?This is expected to boost profitability,? he stresses in a research note.
Aside from this, Tay says that the opening of RafflesHospitalShanghai by mid-FY2021 is something the group can look forward to.
?Being a more cosmopolitan city with a bigger expat presence, demand for private healthcare in Shanghai is expected to be higher,? he mills.
Given the group?s existing presence in Shanghai, he reckons that its EBITDA (earnings before interest, taxes, depreciation and ammortisation) losses will be less than that incurred in the setting up of its RafflesHospitalChongqing.
RafflesHospitalChongqing is still yielding EBITDA losses of below $10 million despite having an increase in patient loads from FY2019.
However, Tay believes it remains on track to break even in FY2021 ?as China has contained Covid-19 swiftly?.
Meanwhile, its operations back home has already seen an improvement in 2H2020, with local patient numbers returning to pre-pandemic levels.
CGS-CIMB?s See is positive that this will continue as the group continues its support of the government?s Covid-19 efforts and national vaccination drive through the four centres it has operations in.
Against this backdrop, she is lifting her forecast for Raffles Medical?s revenue for FY2021-FY2022 ?to account for the continued Covid-19 work [and an] increase [in] tax expenses?.
Tay conversely, has lowered his earnings forecast for FY2021 by 10%, despite his prediction of the year bringing healthy revenue.
This is to factor in RafflesHospitalShanghai?s gestation in 1H2021 as well as the higher expenses related to an expanded business, he explains.
These are also areas of concern to analysts at OCBC Investment Research. ?Weaker than expected ramp up at its new projects in China, costs containment issues impacting overall margins,? are other investment risks they foresee.
Still, three out of four of the analysts have posted ?buy? or ?accumulate? calls on Raffles Medical Group.
PhillipCapital?s Tay has a target price of $1.18, while analysts at OCBC Investment Research have a $1.15 target. Maybank Kim Eng?s Lai?s target is $1.10.
See has conversely maintained her ?hold? call at a higher target price of $1.10. This is up from her previous 96 cent call and is believed to give the counter a 7.9% upside from its $1.02 price on Feb 22.
Shares in Raffles Medical Group closed up 20 cents or 1.18% at $1.12 on Mar 2.
|
|
Good Post
Bad Post
|
x 0
x 0
|
Look good... 👍 🤔
|
|
Good Post
Bad Post
|
x 0
x 0
|
Just wait and see how
wiltay ( Date: 28-Feb-2021 18:01) Posted:
wiltay ( Date: 28-Feb-2021 17:59) Posted:
Be patient a bit lah...
This counter not just into construction sector but also into Bio-refinery and bio-energy which look very
optimistic. I am looking forward for good dividend next round.
|
|
|
|
|
|
Good Post
Bad Post
|
x 0
x 0
|
This counter so quiet only 15lot done on Friday.. like no ppl interested. Not very optimistic.
wiltay ( Date: 25-Feb-2021 10:55) Posted:
Relax lah..... hold it for long term
ahberngh ( Date: 25-Feb-2021 10:50) Posted:
Wrong, I am already invested but underwater  |
|
|
|
|
|
Good Post
Bad Post
|
x 0
x 0
|
Any possible to reach $1.5
|
|
Good Post
Bad Post
|
About Laihuat68
Go to Message
